DSGN
Price:
$6.21
Market Cap:
$351.62M
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysfunction; and Myotonic Dystrophy Type-1 (DM1), a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs. It is also developing GeneTAC product candidate portfolio for the treatment o...[Read more]
Industry
Biotechnology
IPO Date
2021-03-29
Stock Exchange
NASDAQ
Ticker
DSGN
According to Design Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 34.61. This represents a change of -4.00% compared to the average of 36.05 of the last 4 quarters.
The mean historical Current Ratio of Design Therapeutics, Inc. over the last ten years is 29.84. The current 34.61 Current Ratio has changed 11.50% with respect to the historical average. Over the past ten years (40 quarters), DSGN's Current Ratio was at its highest in in the June 2021 quarter at 118.91. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
29.84
Median
29.58
Minimum
0.02
Maximum
72.96
Discovering the peaks and valleys of Design Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 64.37%
Maximum Annual Current Ratio = 72.96
Minimum Annual Increase = -57.37%
Minimum Annual Current Ratio = 0.02
Year | Current Ratio | Change |
---|---|---|
2023 | 29.58 | -4.89% |
2022 | 31.10 | -57.37% |
2021 | 72.96 | 369.16% |
2020 | 15.55 | 64.37% |
The current Current Ratio of Design Therapeutics, Inc. (DSGN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
44.54
5-year avg
29.84
10-year avg
29.84
Design Therapeutics, Inc.’s Current Ratio is greater than Monte Rosa Therapeutics, Inc. (6.03), greater than Werewolf Therapeutics, Inc. (10.10), greater than Ikena Oncology, Inc. (15.32), greater than Stoke Therapeutics, Inc. (5.09), greater than Achilles Therapeutics plc (6.04), greater than Neoleukin Therapeutics, Inc. (15.33), greater than Magenta Therapeutics, Inc. (14.64), greater than Graphite Bio, Inc. (11.47), greater than ALX Oncology Holdings Inc. (4.82), greater than Aadi Bioscience, Inc. (4.89), greater than ADC Therapeutics SA (4.92), less than AlloVir, Inc. (86.78), greater than Gracell Biotechnologies Inc. (7.73), greater than Theseus Pharmaceuticals, Inc. (29.93), greater than Erasca, Inc. (11.00), greater than Cullinan Oncology, Inc. (24.46), greater than Immunocore Holdings plc (3.78), greater than C4 Therapeutics, Inc. (6.31),
Company | Current Ratio | Market cap |
---|---|---|
6.03 | $438.66M | |
10.10 | $69.96M | |
15.32 | $80.59M | |
5.09 | $614.95M | |
6.04 | $40.33M | |
15.33 | $8.20M | |
14.64 | $42.44M | |
11.47 | $185.19M | |
4.82 | $98.63M | |
4.89 | $70.49M | |
4.92 | $192.41M | |
86.78 | $52.01M | |
7.73 | $989.87M | |
29.93 | $181.50M | |
11.00 | $701.16M | |
24.46 | $691.16M | |
3.78 | $1.41B | |
6.31 | $286.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Design Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Design Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Design Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Design Therapeutics, Inc. (DSGN)?
What is the highest Current Ratio for Design Therapeutics, Inc. (DSGN)?
What is the 3-year average Current Ratio for Design Therapeutics, Inc. (DSGN)?
What is the 5-year average Current Ratio for Design Therapeutics, Inc. (DSGN)?
How does the current Current Ratio for Design Therapeutics, Inc. (DSGN) compare to its historical average?